CBS 2019
CBSMD教育中心
中 文

Scientific Library

Abstract

Recommended Article

Management of Percutaneous Coronary Intervention Complications: Algorithms From the 2018 and 2019 Seattle Percutaneous Coronary Intervention Complications Conference Guidelines in review: Comparison of the 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes and the 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation Effectiveness-Based Guidelines for the Prevention of Cardiovascular Disease in Women—2011 Update: A Guideline From the American Heart Association Quality of Life after Everolimus-Eluting Stents or Bypass Surgery for Treatment of Left Main Disease Two-Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure Screening for Atrial Fibrillation With Electrocardiography US Preventive Services Task Force Recommendation Statement Long-term clinical outcomes after treatment of stent restenosis with two drug-coated balloons The year in cardiovascular medicine 2020: heart failure and cardiomyopathies

Original Research2020 Jun 7;128:110336.

JOURNAL:Biomed Pharmacother. Article Link

Comparison of the Preventive Efficacy of Rosuvastatin Versus Atorvastatin in Post-Contrast Acute Kidney Injury in Patients With ST-segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention

YN Dai, JL Huang, DQ Yu et al. Keywords: atorvastatin; rosuvastatin; STEMI; PCI; post-contrast acute kidney injury

Full Text PDF